Long-term diazoxide treatment in persistent hyperinsulinemic hypoglycemia of infancy: a patient report.
Long-term diazoxide and somatostatin analogue have been used in the treatment of persistent hyperinsulinemic hypoglycemia of infancy albeit with some side effects. We report a case with persistent hyperinsulinemic hypoglycemia who has been on diazoxide therapy for 4.5 years. Diazoxide treatment maintained normoglycemia without causing any side effects, including hypertrichosis.
Darendeliler
F
F
Department of Pediatrics, Faculty of Medicine, Istanbul University, Turkey.
Bundak
R
R
Bas
F
F
Saka
N
N
Günöz
H
H
D001786:Blood Glucose / Q000378:metabolism; D003981:Diazoxide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006946:Hyperinsulinism / Q000150:complications*; D007003:Hypoglycemia / Q000188:drug therapy* / Q000209:etiology*; D007223:Infant; D008297:Male
D001786:Blood Glucose; D003981:Diazoxide